[[Merck]] has developed a [[vaccine]] against the four most prevalent sexually transmitted strains of HPV; see [[Gardasil]]. [[GlaxoSmithKline]] later released its own vaccine, Cervarix, which protects against the two most prevalent high risk strains. Both vaccines are manufactured using recombinant viral capsid proteins. | [[Merck]] has developed a [[vaccine]] against the four most prevalent sexually transmitted strains of HPV; see [[Gardasil]]. [[GlaxoSmithKline]] later released its own vaccine, Cervarix, which protects against the two most prevalent high risk strains. Both vaccines are manufactured using recombinant viral capsid proteins. |